9 studies found for:    acc-001
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Biological: ACC-001 (vanutide cridificar)
2 Completed Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: ACC-001 3 μg/ QS-21 50 μg;   Biological: ACC-001 10 μg/ QS-21 50 μg;   Other: Placebo- Phosphate buffered saline (PBS)
3 Completed Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: ACC-001 + QS-21;   Biological: ACC-001;   Biological: QS-21;   Drug: Placebo: Phosphate buffered saline
4 Completed Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: ACC-001 + QS-21;   Biological: QS-21;   Other: Diluent: Phosphate Buffered Saline;   Biological: ACC-001
5 Completed Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: ACC-001;   Other: QS-21;   Other: PBS
6 Completed Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: ACC-001+ QS21;   Drug: ACC-001;   Drug: ACC-001 + QS21
7 Completed Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Biological: ACC-001
8 Completed A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: ACC-001+ QS21
9 Completed Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: ACC-001;   Other: QS-21

Indicates status has not been verified in more than two years